PAVmed Inc. (PAVM)

[MaineMan5]

Am using this drop to pick up as many new shares as I can. I consider this just a 30-45 day delay (at most), nothing more. The science is still intact and the lead branch voted in favor of approval. It was the consulting branch that did not, and time expired on their application. What was strange during the CC Wed was the CEO said that while the consulting branch did not grant approval, they did not cite anything specifically wrong or that needed to be corrected before granting approval. The CEO said the lead branch reached out to PAVM and said "we are quite confused as to why the consulting branch did not give the nod and we want to work with you to get this thing going." He mentioned this a few times during the CC. He also indicated they were talking to FDA late this week to determine what they need to do for approval. CEO said they have gone above and beyond what was originally asked for and all data came back highly supportive of approval. He also indicated if it was something simple, it could maybe be taken care of in a matter of days, not weeks. While disappointing, in the end, I think they will secure approval shortly. All JMO GLTA.